Patent application number | Description | Published |
20090203886 | HUMANIZED ANTI CD20 MONOCLONAL ANTIBODY - The present invention provides a humanized anti human CD20 monoclonal antibody, selection criteria therefor, humanized antibodies selected using that criteria and showing biological characteristics suitable for use as pharmaceuticals. | 08-13-2009 |
20100015638 | Method for production of antibody directed against cell membrane surface antigen epitope and assaying method - Disclosed are a method for determining the affinity of an antibody capable of binding to a cell membrane surface antigen for the antigen; and a method for assaying or screening an antibody capable of binding to a cell membrane surface antigen by utilizing the determination method. In the determination of the affinity of the antibody for the antigen, floating cells presenting the antigen on the surface of the cell membrane thereof are used and the B/F separation of the cells is made by centrifugation or on a filter through which the cells cannot pass. | 01-21-2010 |
20100172555 | FEATURE QUANTITY SELECTION METHOD, FEATURE QUANTITY SELECTION APPARATUS, IMAGE CLASSIFICATION METHOD, IMAGE CLASSIFICATION APPARATUS, COMPUTER PROGRAM, AND RECORDING MEDIUM - A control unit ( | 07-08-2010 |
20110045009 | Cell Permeable Peptide - The number of peptides having an ability to bind to a cell or penetrate into a cell is narrowed down by being selectively enriched from a random peptide library with a diversity of not less than one hundred millions of peptides using a phage surface display technique, and then cytoplasmic transfer is evaluated by using protein synthesis inhibition as an indicator by adding to a cell, a fusion body of the selectively enriched peptide and a protein synthesis inhibitory factor (PSIF) that cannot solely penetrate into the cell. | 02-24-2011 |
20110263825 | ANTI-CD20 MONOCLONAL ANTIBODIES - It is intended to provide a monoclonal antibody having a growth inhibitory activity against a cell having a human CD20 antigen which is produced by using, as immunogens, a human B cell line expressing the human CD20 antigen and a cell line originating in a non-human animal, which is different from an animal to be immunized and has been transformed with human CD20 DNA, and a monoclonal antibody obtained by chimerization or humanization of the above-described monoclonal antibody. These monoclonal antibodies show biological activities suitable for using as drugs. | 10-27-2011 |
20120140217 | OPTICAL MICROSCOPE AND OPTICAL INSTRUMENTATION - The invention provides an optical microscope that prevents an increase in the complexity of the light source system and is equipped with optics readily capable of adequate operation even when the modulation frequency is increased in order to reduce the impact of the intensity noise of the laser, etc. This optical microscope | 06-07-2012 |
20140104608 | OPTICAL MICROSCOPE AND OPTICAL INSTRUMENTATION - An optical microscope that can prevent an increase in the complexity of the light source system is equipped with optics readily capable of adequate operation even when the modulation frequency is increased to reduce the impact of the intensity noise of the laser. The optical microscope irradiates a sample with a first train of optical pulses having a first optical frequency, which is generated by a first light source, and a second train of optical pulses having a second optical frequency, which is temporally synchronized with the first train of optical pulses and is generated by a second light source, and detects light scattered from the sample. A first repetition frequency of the first train of optical pulses is an integral sub-multiple of a second repetition frequency of the second train of optical pulses. | 04-17-2014 |
20150060280 | METHOD FOR CLASSIFYING AND DISCRIMINATING JATROPHA LINES USING RETROTRANSPOSON AS A MARKER - lines can be classified and discriminated by a method including the steps of: conducting a nucleic acid amplification reaction using a primer set including (i) adjacent forward primer and (ii) adjacent reverse primer, and (iii) LTR forward primer or LTR reverse primer, or (iv) RTP forward primer or RTP reverse primer, wherein DNA prepared from | 03-05-2015 |